To reduce the impact of this dilemma, employers in great numbers have contracted with wellness companies that promise to reduce healthcare utilization through concerted efforts to get employees healthier, or at least keep them well. The idea is that an overall healthier workforce leads to less healthcare utilization, which, in turn, should reduce the subsequent year’s rate of insurance premium increases. (Note: a company’s health insurance premiums are in part determined by the extent to which the employees of that company have utilized healthcare in the previous year – in short, the more healthcare a employees obtain this year, the greater the company’s premiums will be next year.) Conceptually, this move to contract with wellness companies to get employees healthier seems like a good idea, as it is logical that it should reduce the cost of the following year’s premiums. Empirically, however, the wellness industry has yet to demonstrate convincingly that they can successfully carry out their promise of reduced insurance premium costs through employee health improvement.
Meanwhile, the cost of insurance continues to rise.
Maybe it’s time to think outside the box. How else could employers reduce the annual cost of insurance premiums?
Perhaps, it’s time for employers to become more knowledgeable about what they are buying with their health insurance and begin to determine, in some broad ways, what their health insurance tends to pay for and what costs subsequently get passed onto them in the form of insurance premiums. Specifically, they could become more knowledgeable of the fact that they are buying health insurance, which routinely pays for care that is known to be ineffective on average.
That is to say, employers buy into a system that provides care to their employees, but some routine forms of care typically do not make their employees healthier or return them to work faster. Health providers nonetheless deliver such care and insurance companies pay for it and then pass on the costs to employers in the form of premiums. And employers unknowingly and routinely allow it.
Why is that?
Companies typically keep a close eye on their costs. They make it their business to know enough about, say, their various suppliers’ operations to know if or when their suppliers are engaged in ineffective practices the cost of which are subsequently getting passed on to them. They don’t remain ignorant of these potential costs. As such, they can assert pressure on their suppliers to either clean up their act and reduce costs or the company can go elsewhere to get their supplies.
Historically, however, employers have remained ignorant of the practices related to the suppliers of employee healthcare. They buy into a system of healthcare providers and insurance companies and subsequently trust that the latter two entities will regulate themselves to always act in the best interest of the employer.
Maybe it’s time for employers to become knowledgeable enough about healthcare to know what they are buying with all that insurance premium money. Maybe it’s time for employers to at least know if their employees are getting effective care or not. Such knowledge brings the power to reduce costs. Employers would subsequently know enough to stop paying for care that is known to be ineffective on average.
Do people get care that's known to be ineffective?
It may be surprising to learn that the healthcare industry commonly delivers care that is known to be ineffective on average. Let’s take the case of common therapeutic procedures for low back pain. Low back pain is one of the most common reasons for seeking care with a healthcare provider.4 Over the last few decades, the delivery of spinal injections, spinal surgeries and the use of narcotic pain medications have risen exponentially.5 However, numerous clinical trials, reviews and meta-analyses of these therapies show that at best they are not very effective.6, 7, 8, 9, 10, 11
In the case of low back surgeries, for example, Brox, et al.12 undertook a study comparing lumbar fusion to a treatment consisting of nine physical therapy appointments plus a one-hour facilitated discussion about coping with back pain. They found that the fusion surgery was helpful, but no more helpful than the conservative treatment. Importantly, for our discussion, and for employers who are buying the insurance that pays for such care, the cost of fusion surgery is exceptionally more expensive than physical therapy and a one-hour discussion. Despite this added cost, there is no added value to the fusion.
Narcotic, or opioid, medications are commonly prescribed for back pain despite their lack of proven effectiveness. In worker’s compensation cases, for instance, those who receive the medications have up to 14 times higher risk for chronic work loss when compared to those who don’t receive the medications.13 A previous study showed that the use of narcotic medications early after onset of a low back pain is similarly associated with greater work loss – with being out of work for up to nine weeks more than those who don’t receive the medications.14 Again, despite these findings, narcotic pain medications are ubiquitously used for low back pain and insurance companies routinely pay for it. They subsequently pass these costs on to employers in the next year’s premium increases. Just as routinely, employers pay for these premiums or further pass on the costs to their employees. As such, in this instance, employers or their employees are paying into a system that keeps workers out of work longer.
So, what can employers do about paying for ineffective care?
Employers should get educated on what they are buying
In years past, it might seem unheard of to question our system of healthcare. After all, it’s a social norm to do what the doctor tells us to do. Societally, we rely on the ethics of the healthcare professions to regulate themselves and we simply trust that healthcare professionals will always work in our best interests. It’s time, though, to be concerned about this heretofore unquestioned trust.
Employers should treat their suppliers of healthcare like they treat any of their other suppliers. It’s time for employers to perform a supply chain analysis of the suppliers of healthcare.
To do so, employers need to educate themselves on what is effective and what is not effective. There are any number of organizations, such as the Institute for Chronic Pain, the NNT, the Choosing Wisely initiative, or the Dartmouth Institute for Health Policy and Clinical Practice, whose missions are to bring this information to the public.
Perhaps too, wellness companies should get in on the act. They could contract with knowledge holders in organization like those above to develop educational campaigns aimed at employees. They could teach employees what works and what doesn’t for common ailments so that down the road, maybe the average employee might think twice when, say, they get a referral to the spine surgeon for a new onset of low back pain.
Teaming up with insurance companies and wellness companies
Now, of course, health insurance companies know these data on the effectiveness of therapies and procedures. At times, they even try to introduce limits on the delivery of ineffective care as they too have an incentive to do so.
Commonly, however, such attempts fail because they succumb to the power of healthcare provider groups and their political allies. Political charges of rationing care when combined with our societal trust in healthcare providers are powerful weapons. Employees thus become upset and angry when their doctors tell them they need a treatment but the insurance company won’t pay for it. Such ire gets subsequently expressed towards employers who were the original buyers of the health insurance. All the stakeholders come to see the insurance companies as the bad guy, only out for themselves at the expense of the hapless patient employee. Out of fear that such perceptions will lead to a loss of the employer’s business next year, insurance companies back down and resume paying for the ineffective care on a routine basis.
Notice, however, that the charge of rationing care can only stand when all the stakeholders in the system, with the exception of the insurance companies, remain ignorant of the data showing the care to be ineffective. In other words, the charge of ‘rationing care’ can only succeed in a data vacuum. If everyone in the system knew that the therapy in question was ineffective, then the insurance companies’ policy change to limit the care would make more sense and many would come to agree with it -- and subsequently disagree with the healthcare provider who is recommending the ineffective care.
As such, insurance companies make natural allies to employers and even, in this instance, to employees who use their insurance to obtain health care. What’s needed is for employers to step up to the plate and educate themselves and their employees as to what is and what is not effective for common health conditions. With the right educational campaign, a combination of employers, insurance companies and wellness companies might succeed at fostering more informed consumers of healthcare that would serve as a regulatory balance to the excessive delivery of ineffective care by healthcare providers. In so doing, more informed healthcare decision-making on the part of employees would lead to reduced utilization of services, which, in turn, would lead to lowered premiums for the following year. It’s win-win-win for employers, employees, and insurance companies.
References
1. Kennedy, K. (June 5, 2014). Premiums grew average 10% before Affordable Care Act. USA Today. Retrieved from: http://www.usatoday.com/story/news/nation/2014/06/05/premiums-grew-average-of-10-before-affordable-care-act/9960093/
2. Mangan, D. (October 3, 2014). Sticker shock? Not. Obamacare’s proposed 2015 rates. CNBC. Retrieved from: http://www.cnbc.com/id/102055144
3. Ungar, R. (October 31, 2014). Key study on Obamacare 2015 premium rates is out and you won’t believe what’s going to happen. Forbes. Retrieved from: http://www.forbes.com/sites/rickungar/2014/10/31/key-study-on-obamacare-2015-premium-rates-is-out-and-you-wont-believe-whats-going-to-happen/
4. St. Sauver, J.L., Warner, D. O., Yawn, . P… Rocca, W. A. (2013). Why patients visit their doctors: Assessing the most prevalent conditions in a defined US population. Mayo Clinic Proceedings, 88(1), 56-67. doi: 10.1016/j.mayocp.2012.08.020
5. Deyo, R. A., Mirza, S. K., Turner, J. A., & Martin, B. I. (2009). Overtreating back pain: Time to back off? Journal of the American Board of Family Medicine, 22(1), 62-68. doi: 10.3122/jabfm.2009.01.080102
6. Bickett, M. C., Gupta, A., Brown, C. H., & Cohen, S. P. (2013). Epidural injections for spinal pain: A systematic review and meta-analysis evaluating the “control” injections in randomized controlled trials. Anesthesiology, 119(4), 907-931. doi: 10.1097/ALN.0b013e31829c2ddd
7. Gibson J. N., & Waddell, G. (Updated January 6, 2007). Surgical intervention for lumbar disc prolapse. In Cochrane Database of Systematic Reviews, 2007 (2). Retrieved November 25, 2011, from The Cochrane Library, Wiley Interscience.
8. Iverson, T., Solberg, T. K., Romner, B., Wilsgaard, T., Twisk, J., Anke, A., Nygaard, O., Hasvold, T., & Ingebrigtsen, T. (2011). Effect of caudal epidural steroid or saline injection in chronic lumbar radiculopathy: Multicentre, blinded, randomized controlled trial. BMJ, 343, d5278. doi: 10.1136/bmj.d5278
9. Martell, B. A., O’Connor, P. G., Kerns, R. D., Becker, W. C., Morales, K. H., Kosten, T. R., Fiellin. D. A. (2007). Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Annals of Internal Medicine, 146, 116-127.
10. Staal, J. B., de Bie, R., de Vet, H. C., Hildebrandt, J., & Nelemans, P. (2008). Injection therapy for subacute and chronic low-back pain. Cochrane Database of Systematic Reviews, 3(3). doi: 10.1002/14651858.CD001824.pub3
11. van Middelkoop, M., Rubinstein, S. M., Ostelo, R., van Tulder, M. W., Peul, W., Koes, B. W., & Verhagen, A. P. (2012). Surgery versus conservative care for neck pain: A systematic review. European Spine Journal, 22(1), 87-95. doi: 10.1007/s00586-012-2553-z
12. Brox, I., Sorensen, R., Friis, A… & Reikaras, O. (2003). Randomized clinical trial of instrumented fusion and cognitive intervention and exercises in patients with chronic low back pain and disc degeneration. Spine, 28(17), 1913-1921. doi: 10.1097/01.BRS.0000083234.62751.7A
13. Volinn, E., Fargo, J. D., & Fine, P. G. (2009). Opioid therapy for nonspecific low back pain and the outcome of chronic work loss. Pain, 142, 194-201.
14. Webster, B. S., Verma, S. K., & Gatchel, R. J. (2007). Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use. Spine, 32, 19, 2127-2132.
Date of publication: Januay 7, 2015
Date of last modification: October 23, 2015
